Cargando…
N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells
Emergence of drug resistance to chemotherapeutic agents is the principal obstacle towards curative cancer treatment in human cancer patients. It is in an urgent to explore the underlying molecular mechanisms to overcome the drug resistance. N6-Methyladenosine (m6A) RNA modification is the most abund...
Autores principales: | Wang, Chuhan, Danli ma, Yu, Huimin, Zhuo, Zhihong, Ye, Zhiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006539/ https://www.ncbi.nlm.nih.gov/pubmed/36915498 http://dx.doi.org/10.1016/j.heliyon.2023.e14001 |
Ejemplares similares
-
The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis
por: Chen, Mengnuo, et al.
Publicado: (2020) -
The crucial roles of N(6)-methyladenosine (m(6)A) modification in the carcinogenesis and progression of colorectal cancer
por: Fang, Zhihao, et al.
Publicado: (2021) -
METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
por: Yue, Ben, et al.
Publicado: (2019) -
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial–Mesenchymal Transition of Cancer Cells
por: Li, Jiexin, et al.
Publicado: (2020) -
Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)